- Exogenous pulmonary surfactant replacement therapy in a neonate with pulmonary hypoplasia accompanying congenital diaphragmatic hernia: a case report
-
Bae CW, Jang CK, Chung SJ, Choi YM, Oh SM, Lee TS, Shin OY
- KMID: 644960
- J Korean Med Sci.
- 1996 Jun;11(3):265-270.
- doi: 10.3346/jkms.1996.11.3.265
Pulmonary hypoplasia(PH) commonly occurs in association with oligohydramnios and other congenital anomalies, especially congenital diaphragmatic hernia (CDH). Pulmonary hypoplasia is an important factor, as persistent pulmonary hypertension, in the prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years
-
Bae CW, Hahn WH
- KMID: 1783141
- J Korean Med Sci.
- 2009 Dec;24(6):1110-1118.
- doi: 10.3346/jkms.2009.24.6.1110
We undertook a multi-hospital collective study to evaluate outcomes of neonatal respiratory distress syndrome (RDS) patients treated with pulmonary surfactant (PS) over 17 yr in Korea (Group I; 1990/91, Group... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Clinical Efficacy of Newfactan(R) versus Surfacten(R) for the Treatment of Respiratory Distress Syndrome in the Newborn Infants
-
Choi CW, Hwang JH, Yoo EJ, Kim KA, Koh SY, Lee YK, Shim JW, Lee EK, Chang W, Kim SS, Chang YS, Park WS, Shin SM
- KMID: 1712738
- J Korean Med Sci.
- 2005 Aug;20(4):591-597.
- doi: 10.3346/jkms.2005.20.4.591
Newfactan(R) is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan(R) with that of Surfacten(R) in the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
